Nifty
Indian Pharma Stocks Fall on Trump's Generic Drug Tariff Plan
Lumic
about 2 months ago
Indian Pharma Stocks Fall on Trump's Generic Drug Tariff Plan
Nifty Pharma declined as Trump's proposed tariff plan weighed on export outlook.
Imported generic drugs stay duty-free for two years before phased US tariffs begin.
India's major drugmakers face long-term uncertainty in their largest export market.
LUMIC INSIGHT
Pharma shares likely to be under pressure in coming days
This 'Insights' piece discusses the recent downturn in Indian pharma stocks. The Nifty Pharma index saw a decline following news of a proposed US plan to impose tariffs on generic drugs. While imported generic drugs will remain duty-free in the US for two years, the subsequent phased tariffs introduce long-term uncertainty for India's major drugmakers, who rely heavily on the US market for exports. This development is causing pressure on pharma shares, highlighting the impact of global trade policies on the Indian stock market and the pharmaceutical sector. Investors and industry watchers are closely monitoring the situation for potential further impacts on the Indian economy.
More in Nifty
Lumic
1 day ago
Nifty
2026 IPOs: HDB Financial Leads, 7 of Top 10 Gain 30%+ on First Listing Day!
Lumic research ·
Lumic
4 days ago
Nifty
Closing Auction Session Cuts Derivatives Volume, Raising Liquidity concern
- August derivatives turnover hit multi-month lows on NSE and BSE after CAS changed trading
- NSE's August derivatives turnover fell to ₹34.48 lakh crore, lowest since November 2023
- Traders are closing positions earlier, reducing arbitrage and hedging activity near close
LUMIC INSIGHT
CAS volatility a big challenge for derivative traders
Economic Times·